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Abstract 
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder which needs adequate studies on effective 
treatment options. The extracts of plants and their effect on the amelioration of AD symptoms have been 
extensively studied. This review summarizes the use of medicinal plants in treatments and management of 
Alzheimers disesase, its mechanisms and active primary metabolite responsible for its mode of action and possible 
future development of this plant extracts into phytopharmaceuticals.The medicinal plants used in management of 
Alzheimers disease in Africa particularly in Nigeria includes: Yizhi Jiannao, Moringa oleifera (Drumstick tree), 
Cassia obtisufolia (Sicklepod), Desmodium gangeticum (Sal Leaved Desmodium), Melissa offiffiffi cinalis 
(Lemon Balm), and Salvia offiffiffi cinalis (Garden sage, common sage).  
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1.1 INTRODUCTION 
1.12 MEDICINAL PLANTS 
Herbal medicines and natural products are the oldest remedies known to mankind. Medicinal plants have been 
used by all cultures throughout the history. In present scenario, the demand for herbal products is growing, 
exponentially throughout the World. In human body, the nervous system coordinates and regulates the various 
voluntary and involuntary activities of the body. The central nervous system and the autonomic nervous system 
are interlinked and some drugs affect the CNS producing reactions associated with the autonomic system 
(McCorry, 2007). Drugs involved with the CNS may have general stimulatory or depressant action with anti-
convulsant and psychopharmacological activities. Memory deficit is a major global health problem. Current 
therapies are inadequate and have numerous adverse effects. There is an urgent need for possible alternative 
treatments for AD and memory deficit. Various medicinal plants are prescribed to enhance the memory. We have 
reviewed the literature on medicinal plants used in the treatment of AD and memory deficit (Xu et al., 2009). 
Several medicinal plants have been used for decades in different cultures to improve memory such as Valeriana 
officinalis, Punica granatum L., Salvia of-ficinalis, Myristica fragrans Bacopa monnieri Linn, Centella asiatica 
Linn and Evolvulus alsinoides Linn. Elufioye et al. (2012) reported some plants used as anti-aging and memo-ry 
enhancing activities in Sagamu, Nigeria that are Bacopa floribunda, Angraecum eichlerianum, Parquet 
inanigrescens, Cleome gynandra, Dalbergia lacteal, Capsicum fructescens, Aframomum melegueta, Digitaria 
debilis, Musa sapientum, Bryophyllum pinnatum, Abrus precatorius, Ficus exasperate, Dioscorea mangenotiana, 
Jatropha curcas, Spondia smombin, Capsicum frutescens, Cola acuminate, Mirabilis jalapa, Elaies guineensis, 
Canna indica, Ipomoea mauritania, Bambusa vul-garis, Cordia millenii, Piper guineense, Dioclea sarmentosa, 
Cucumeropsis mannii, Eleusine indica, Ocimum basilicum, Khaya ivorensis, Carpolobia alba, Carapa procera, 
Entandro-phragma utile, Xylopiaae thiopica, Garcinia kola, Theobroma cacao, Milicia excels, Blighia sapida, 
Baphia nitida, Peperomia pellucid, Vernonia amygdalina and Zea mays. Jazayeri et al. (2014) reported some plants 
having anticholinesterase ac-tivity such as Brassica alba, Brassica nigra, Camellia sinensis, Cinchona officinalis, 
Citrus aurantifolia, Citrus aurantium, Ferula assafoetida, Humulus lupulus, Juglans regia, Juniperus sabina, 
Myristica fragrans, Pelargonium graveolens, Pistacia vera, Punica granatum, Rheum officinale, Rosa damasce-na, 
Salix alba and Zizyphus vulgaris. Other plants having memory enhancing properties are Juglans regia (Haider et 
al., 2011), Cuminum cyminum (Koppula and Choi, 2011), Ficus religiosa (Kaur et al., 2010), Melissa officinalis 
(Kenne-dy and Scholey, 2006), Rosmarinus officinalis (Ozarowski et al., 2013), Piper nigrum (Hritcu et al., 2014), 
Ginkgo biloba (Tan et al., 2015), Bacopa monnieri (Roodenrys et al., 2002), Desmodium gangeticum (Mahajan et 
al., 2015) and Emblica officinalis Gaerth (Justin Thenmozhi et al., 2016). Herbal medicines have been used to treat 
various ailments in Unani system of medicine since ancient times. However, there is a lack of scientific data on 
the effectiveness and stability of bioactive chemical constituents in medicinal plants. In this review, we aimed at 
documenting the information on plants used as a memory enhancer in AD.Withania somniferaWithania somnifera 
belongs to the family Solanaceae. It (500 mg/d) exhibited calming effects on stress and reversed mem-ory loss 
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(Auddy et al., 2008). Cholinergic activity of Witha-nia somnifera has been reported in a previous study (Schliebs 
et al., 1997). Memory enhancing activity and cognition im-proving property of Withania somnifera increase due 
to its ability to increase acetylcholine level in the brain. Neurotic outgrowth activity of Withania somnifera is 
reported already in human neuroblastoma cells that are time- and dose-de-pendent. Withania somnifera enhances 
dendrite and axon regeneration (Tomoharu et al., 2005). A molecular modeling study indicates that withanamides 
A and C bind to Aβ and inhibit fibril synthesis (Jayaprakasam et al., 2010). Curcuma longaCurcuma longa belongs 
to the family Zingiberaceae. In Southeast Asian countries, prevalence of AD is low due to consumption of turmeric. 
It has anti-inflammatory activity that is also associated with reduced risk of AD (Aggarwal and Harikumar, 2009). 
Curcumin reduces the plaque depo-sition in the brain. Turmeric decreases oxidative stress and amyloid pathology 
(Mishra and Palanivelu, 2008). In one study, administration of low doses of curcumin reduced Aβ level up to 40% 
in mice with AD as compared to control drug (Shytle et al., 2009). Curcumin at low doses caused 43% decrease 
in the plaque burden that these Aβ have on the brain of mice with AD (Mishra and Palanivelu, 2008). A previous 
study indicates that low doses of curcumin admin-istered for long duration are more effective in the treatment of 
AD as compared to higher doses of curcumin (Yang et al. 2005). Curcumin has an ability to bind with Aβ and 
inhibits its self assembly (Reinke and Gestwicki, 2007). Curcumin has powerful anti-inflammatory and antioxidant 
effects (Fan et al., 2015); according to the researchers, these effects help in treating Alzheimer’s symptoms caused 
by inflammation and oxidation (Frautschy and Hu, 2001). Hypercholesterolemia and hyperlipidemia increase 
amyloid plaques by intracellular accumulation of cholesterol esters (Tokuda et al., 2000). Sci-entists believe that 
curcumin might have therapeutic effects on AD by inhibiting cholesterol synthesis and reducing se-rum peroxides 
(Soni and Kuttan, 1992). Convolvulus pluricaulisConvolvulus pluricaulis belongs to the family Convolvulace-ae. 
It is used as a memory enhancing agent. A previous study has shown that aqueous and ethyl acetate extract of 
Convol-vulus pluricaulis increases memory functions and learning abilities (Bihaqi et al., 2011). In another study, 
a wide range of secondary metabolites such as steroids, anthocyanins, flavonol glycosides and triterpenoids have 
been isolated that are responsible for memory enhancing and nootropic prop-erties (Malik et al., 2011). 
Convolvulus pluricaulis has been repoted to calm the nerves by regulating the stress hormones synthesis (cortisol 
and adrenaline) in the body (Sethiya et al., 2009). The ethanolic extract of Convolvulus pluricaulis and its aqueous 
and ethyl acetate fractions significantly improved memory retention and learning abilities in rats (Nahata et al., 
2008). Another study conducted by Bihaqi et al. (2011) indicated that extracts of Convolvulus pluricaulis enhance 
the memory in Wistar rats in a dose-dependent manner. Similarly, administration of Convolvulus pluricaulis for 1 
week increased memory in aged mice (Sharma et al., 2010). Administration of Convolvulus pluricaulis increased 
the ace-tylcholinesterase activity in the hippocampal CA1 and CA3 regions associated with the memory function 
and learning abilities (Dubey et al., 1994). Centella asiatica Centella asiatica belongs to the family Apiaceae. It 
contains saponins, asiaticosides, madecassoside, madasiatic acid, brahmoside, brahminoside, sasiaticoside, 
sitosterol, tannins,ascorbic acid, centoic acid, centellic acid, thankuniside, brahmoside, brahminoside, siatic acid, 
thankuniside, gly-coside, triterpine, thankunic acid, vellarin, asiaticosides, thankuniside, and isothankuniside 
(Siddiqui et al., 2007). Centella asiatica is used in depression, rheumatism, mental weakness, abdominal pain, and 
epilepsy (Gohil et al., 2010). It is diuretic, anti-spasmodic, anti-convulsive, tonic, stimu-lant, emmenagogue, 
antioxidant and spermatogenic (Heidari et al., 2007). Centella asiatica reversed the Aβ pathology and reduced 
oxidative stress response (Amala et al., 2012). Rao et al. (2007) reported that treatment with Centella asiatica (Linn) 
fresh leaf extract enhanced learning ability and memory retention power in Wistar rats. Adult rats of 2.5 months 
old were selected for this study. Three different doses (2, 4, and 6 mg/kg) of extracts were administered for 2, 4, 
and 6 weeks. Spatial learning (T-maze) and passive avoid-ance tests were performed after the treatment period. 
Results were compared with those of age matched control rats. Im-provement in spatial learning was significant 
at the dose of 6 mL of extract. The use of Centella anhanced memory retention that was evident from passive 
avoidance test. This data showed that Centella asiatica enhances learn-ing ability and memory retention power in 
adult rats. Veer-endra and Gupta (2003) reported efficacy of Centella asiaticain AD. Its cognition enhancing 
activities and anti-oxidant effects have been reported. Aqueous extract of Centella asi-atica (100, 200 and 300 
mg/kg) was administered for 21 days in streptozotocin (STZ)-induced cognitive impairment and oxidative stress 
in rats. STZ at 3 mg/kg was intracerebroven-tricularly injected into male Wistar rats bilaterally on days 1 and 3. 
Cognitive behavior was assessed after 13, 14 and 21 days of treatment. Rats were sacrificed for assessment of ox-
idative stress after 21 days of treatment. Cognitive behaviors of rats treated with Centella asiatica extract improved 
signifi-cantly. The maximum response was observed after adminis-tration of extract at the doses of 200 and 300 
mg/kg. Results from Veerendra and Gupta (2003) showed that Centella asiatica is effective in STZ-induced 
cognitive impairment in rats. Celastrus paniculatus Celastrus paniculatus belongs to the family Celastraceae. It 
prevented neuronal cell damage against hydrogen peroxide toxicity due to its antioxidant activity (Godkar et al., 
2006). Administration of Celastrus paniculatus prevents neuronal cell damage caused by glutamine induced 
toxicity (Godkar et al., 2003). Celastrus paniculatus increases cholinergic ac-tivity that contributes its ability to 
improving memory per-formance (Bhanumathy et al., 2010). Aqueous extract of Cel-astrus paniculatus has 
antioxidant and cognition enhancing properties (Kumar and Gupta, 2002). Celastrus paniculatusextracts protected 
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neuronal cells against hydrogen peroxide induced toxicity in part by virtue of their antioxidant and free radical 
scavenging activities (Katekhaye et al., 2011). Nardostachys jatamansi Nardostachys jatamansi belongs to the 
family Caprifoliace-ae. It contains sesquiterpene valeranone that has been used for treatment of stress (Lyle et al., 
2009). In a study, Nardo-stachys jatamansi exhibited memory retention and learning enhancing abilities in aged 
and young mice and reversed scopolamine and diazepam induced amnesia. Nardostachys jatamansi also reversed 
aging induced amnesia (Joshi and Parle, 2006). Karkada et al. (2012) reported efficacy of Nar-dostachys jatamansi 
in the prevention of stress induced memory deficit.Coriandrum sativum Coriandrum sativum belongs to the family 
Apiaceae. In one study, Coriandrum sativum was given for 45 days for its ef-ficacy on cognitive function in male 
Wistar rats. This study was conducted in comparison with aging, scopolamine and diazepam induced amnesia. 
Coriandrum sativum exhibited memory enhancing effects due to its antioxidant, anti-in-flammatory and 
cholesterol lowering activities (Vasudevan and Milind, 2009). Ficus carica Ficus carica belongs to the family 
Moraceae. It was investi-gated for its effect in retrieval, retention and acquisition of spatial recognition. Ficus 
carica contains quercetin that plays an important role in memory deficit and AD due to its anti-oxidant activity. 
For this study, mice with memory deficit and normal mice were used. Rectangular maze model and Y-maze were 
used to assess efficacy of Ficus carica on cognitive func-tions. Hexane extract (100 and 200 mg/kg) was 
administered to adult swiss Wistar albino mice. In this study, Bacopa monniera and scopolamine were used as 
standard drug and amnestic agent respectively. Ficus carica 200 mg/kg exhibited maximum nootropic response 
that is near to response ex-hibited by a standard drug Bacopa monniera. In conclusion, Ficus carica at lower doses 
exhibits mild memory enhancing effet and higher doses evoke better learning ability and alter behavior (Saxena et 
al., 2013). Ginkgo biloba Ginkgo biloba belongs to the family Ginkgoaceae. It contains bilobalide that has a 
neuroprotective activity (Chandrase-karan et al., 2001). Ginkgo biloba decreases free radical and improves 
memory in patients with AD (Shi et al., 2010). It contains flavonoids that are involved in memory enhance-ment 
(Bastianetto et al., 2000). Gingko biloba prevents neurodegeneration and GABA inhibitory neurotransmis-sion 
induced by hippocampal corticosterone (Walesiuk and Braszko, 2009). Administration of Ginkgo biloba 
significantly improved memory and learning performance in albino rats (Nalini et al., 1992). Ilex paraguariensis 
Ilex paraguariensis belongs to the family Aquifoliaceae. It has a memory enhancing property. It contains vitamin 
B12, B1 and C. Ilex paraguariensis is being used as an anti-dementia agent (Bastos et al., 2007). Its memory 
enhancing property was investigated in different rat models (Colpo et al., 2007). 
1.1.3 Africa and use of Medicinal P;ants in Traditional Medicine 
The use of medicinal plants as a fundamental component of the African traditional healthcare system is perhaps 
the oldest and the most assorted of all therapeutic systems. In many parts of rural Africa, traditional healers 
prescribing medicinal plants are the most easily accessible and affordable health resource available to the local 
community and at times the only therapy that subsists. Nonetheless, there is still a paucity of updated 
comprehensive compilation of promising medicinal plants from the African continent. The major focus of the 
present review is to provide an updated overview of 10 promising medicinal plants from the African biodiversity 
which have short- as well as long-term potential to be developed as future phytopharmaceuticals to treat and/or 
manage the neurological disorder alzeheimers disease. 
African traditional medicine is the oldest, and perhaps the most assorted, of all therapeutic systems. Africa is 
considered to be the cradle of mankind with a rich biological and cultural diversity marked by regional differences 
in healing practices [Aone Mokaila, 2001]. African traditional medicine in its varied forms is holistic involving 
both the body and the mind. The traditional healer typically diagnoses and treats the psychological basis of an 
illness before prescribing medicines, particularly medicinal plants to treat the symptoms [Gurib-Fakimet al., 2010]. 
The sustained interest in traditional medicine in the African healthcare system can be justified by two major reasons. 
The first one is inadequate access to allopathic medicines and western forms of treatments, whereby the majority 
of people in Africa cannot afford access to modern medical care either because it is too costly or because there are 
no medical service providers. Second, there is a lack of effective modern medical treatment for some ailments such 
as malaria and/or HIV/AIDS, and even neurodegenerative disease, alzeheimers disease which, although global in 
distribution, disproportionately affect Africa more than other areas in the world. 
The most common traditional medicine in common practice across the African continent is the use of 
medicinal plants. In many parts of Africa, medicinal plants are the most easily accessible health resource available 
to the community. In addition, they are most often the preferred option for the patients. For most of these people, 
traditional healers offer information, counseling, and treatment to patients and their families in a personal manner 
as well as having an understanding of their patient’s environment [Gurib-Fakim and Mahomoodally, 2013]. Indeed, 
Africa is blessed with enormous biodiversity resources and it is estimated to contain between 40 and 45,000 species 
of plant with a potential for development and out of which 5,000 species are used medicinally. This is not surprising 
since Africa is located within the tropical and subtropical climate and it is a known fact that plants accumulate 
important secondary metabolites through evolution as a natural means of surviving in a hostile environment 
[Manach et al., 20004].The present review aims to explore some medicinal plants in Africa used for treatment of 
neurodegenerative diseases Alzheimers Disease. 
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1.2. Alzheimers Disease 
Alzheimer’s disease (AD) is a neurodegenerative disease affecting older adults. In 1906, Alois Alzheimer, a 
German neuropathologist and psychiatrist discovered AD. About 24 million World population is suffering from 
dementia, in which majority of patients have AD (Ballard et al., 2011). AD is characterized by memory loss, 
behavior deterioration, performance impairment, and thought slowness. The condi-tion is mimicked by severe 
depression (Squire, 1992). Cog-nitive and neural dysfunction occurs due to accumulation of oxidative damage to 
nucleic acid, protein and mitochondria in the brain. In Spain, survey was conducted on 1,637 people above 64 
years of age regarding subjective memory com-plaints (SMC). SMC were reported in 524 persons (32.4%). 
Cognitive performance, mood, sex, education and age are associated with prevalence of SMC. SMC are reported 
in 24% of people between 65 and 69 years of age. SMC increase 57% in people up to 90 years or above group. 
SMC are 52.8% in people with anxiety and depression (Montejo et al., 2011). Severe psychological stress or drug 
use can cause amnesia. Various allopathic medicines are prescribed in AD but they exert side effects. Therefore, 
herbal medicine could be a good source of drugs for treatment of AD and memory defi-cit with fewer or no side 
effects. The present article reviews the medicinal plants that are proven for their efficacy to treat AD and memory 
deficits. Pathogenesis Two characteristic features are seen in the brain of patients with AD. 1. Senile plaques 
contain extracellular deposits of amy-loid-beta (Aβ), a peptide synthesized by breakage of Aβ pre-cursors (genetic 
locus 21q21–22). Abnormal deposits of Aβ are also found in blood vessels.2. Neurofibrillary tangles, dense 
bundles of abnormal fi-bers in the cytoplasm of neurons which consist of an altered form of the microtubular-
associated protein are found in pa-tients with AD (Hoyer, 1992; Iqbal et al., 2005; Kuljis, 2007; Fernandez et al., 
2008; Bamburg and Bloom, 2009). Molecular MechanismThe main features of AD are extracellular Aβ pathology 
and neurofibrillary tau pathology (tangles and threads). For 25 years, most studies have been conducted on the Aβ 
hypothesis of AD pathogenesis and progression (Pimplikar, 2009). But because of failure in clinical trials of Aβ-
targeted treatment and the new concept of prion like propagation of intracellular abnormal proteins, tau has come 
back into the spotlight as a candidate therapeutic target in management of Alzheimer’s disease. Tau pathologies 
are found in a range of neurodegenerative disorders, but extensive analyses of pathological tau in diseased brains 
has indicated that the abnormal tau protein in each disease is structurally distinct [Downloaded free from 
http://www.nrronline.org on Friday, April 3, 2020, IP: 197.210.84.30]661Akram and Nawaz. / Neural 
Regeneration Research. 2017;12(4):660-670.(Avila et al., 2004), supporting the concept that progres-sion of the 
diverse but characteristic tau pathologies occur through prion like seed dependent aggregation. Therefore, 
intervention in the conversion of normal tau to abnormal forms and in cell-to-cell transmission of tau may be the 
key for development of disease modifying treatment of AD and other memory deficits (Hasegawa, 2016).Drug 
TargetsThe tau and amyloid hypothesis has led to focus on tau and amyloid as treatment targets. The current 
therapeutic goals are to decrease amyloid levels and prevent amyloid toxicity/aggregation and tau 
aggregation/phosphorylation. AD has a heterogenous cause with a large percentage termed sporadic AD arising 
from unknown etiology and a smaller fraction of early onset familial AD caused by mutation in various genes, 
such as the persenilins (PS1, PS2) and β amyloid precursor protein (APP) (Tang, 2003; Bird, 2008). Other genes 
such as apolipoprotein E (APOE) are considered to be a risk factor for AD (Kim et al., 2009). Various proteins 
such as APOE, APP, BACE (Aβ cleaving enzyme), PS1/2, secretases and tau play an important role in the 
pathogenesis of AD. Therefore, research is focused to develop new inhibitors for PS1, BASE and secretase for 
treatment of AD. There is also a significant advancement in understanding the cholinesterase function in the brain 
and the use of cholinesterase inhibitors in management of AD (Wilkinson et al., 2004; Yiannopoulou and 
Papageorgiou, 2013). The mechanism of new generation of acetyl and butyryl cholinesterase inhibitors is being 
studied and investigated in clinical trials for AD (Grossberg, 2003). Other strategies, such as hormone therapy, 
anti-oxidants, cholesterol lowering agents, anti-inflammatory agents and vaccinations are also being investigated 
for treating AD (La-hiri et al., 2002). Drug Treatment The demonstration of damage to the cholinergic pathways 
in the brain leads to great interest in drug development. Ace-tylcholinesterase inhibitors are usually prescribed to 
treat AD. These drugs help in enhancing cognitive functions such as memory and thoughts. These medicines are 
effective in patients with mild to moderate AD (Houghton and Howes, 2005). Tacrine (a cholinesterase inhibitor) 
at a high dose (160 mg/d) was reportedly used in the treatment of AD (Schnei-der, 2000). Tacrine was investigated 
in both clinical trials and neuropsychological test scores, in a 30 week randomized placebo controlled trial (Knapp 
et al., 1994). However, the use of tacrine is limited due to adverse effects such as hepa-totoxicity (Watkins et al., 
1994). Anti-oxidants are effective for AD because they aid in reducing the free radicals that damage the brain cells 
(Howes and Houghton, 2012). Probiotics have been reported for their efficacy to enhance memory (Lyte, 2011). 
Probiotics are used as antidepressant in AD. It reduces anxiety like behavior and attenuates psy-chological stress. 
Neurochemicals are produced by microbes. Immunological and neurological effects are induced by probiotics. 
Probiotics also have immunomodulating ac-tivity (Misra and Medhi, 2013). In Chinese and Ayurvedic medicines, 
medicinal plants are used to treat AD, neurode-generative changes and cognitive diseases. Various western 
medicines being used in memory loss are derived from plants. Plant derived alkaloids such as anticholinesterase 
have been used to treat AD. In the United Kingdom, plant derived galantamine is also used in the treatment of 
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neuro-degenerative disorders. Five million Americans are suffering from AD and this number will increase up to 
7.7 million in 2030. Symptoms of neurodegenerative disorders clearly ap-pear after 60 years of age (Chengxuan 
et al., 2009). Etiology of neurodegenerative disorders is linked to genetic defect that is 10–15% of total cases. In 
AD, loss of neurons appears in subcortical structure, cortex and hippocampus. Various compounds have been 
identified by phytochemical studies such as alkaloids, sterols, triterpenes, polyphenols, tannins, flavonoids and 
lignins that have pharmacological activities including anti-cholinesterase and anti-amyloidogenic. Medicinal 
plants are playing a significant role in the management of AD and memory deficit. The important traditional 
therapeutic methods are Ayurvedic, homeopathy, Unani and Sidha systems of medicine. Unani system of medicine 
offers traditionally a highly scientific health care therapy as a divine gift and as a result the global interest of the 
medical profession is focused on medicinal plants. Traditional system of medicine is fundamentally preventive, 
protective, nutritive and curative. Therefore, traditional medicines are safe and harmless which treat the patients 
with fewer or no side effects. Herbal medicines have their origins in ancient cultures, including those of the 
Egyptian, Indians and Chinese. It involves the use of medicinal plants to treat AD and enhances general health and 
well beings. In fact, many pharmaceutical drugs are based on the synthesized adaptations of naturally occurring 
compounds found in plants. In recent years, interest in herbal medicine has increased, leading to a greater scientific 
interest in the medicinal use of plants in treating disease and improving health, often without any significant side 
effects.  
 
1.3. Pathogenesis  
Two characteristic features are seen in the brain of patients with AD.  
1. Senile plaques contain extracellular deposits of amyloid-beta (Aβ), a peptide synthesized by breakage of Aβ 
precursors (genetic locus 21q21–22). Abnormal deposits of Aβ are also found in blood vessels.  
2. Neurofibrillary tangles, dense bundles of abnormal fibers in the cytoplasm of neurons which consist of an altered 
form of the microtubular-associated protein are found in patients with AD (Hoyer, 1992; Iqbal et al., 2005; Kuljis, 
2007; Fernandez et al., 2008; Bamburg and Bloom, 2009).  
 
1.4. Molecular Mechanism  
The main features of AD are extracellular Aβ pathology and neurofibrillary tau pathology (tangles and threads). 
For 25 years, most studies have been conducted on the Aβ hypothesis of AD pathogenesis and progression 
(Pimplikar, 2009). But because of failure in clinical trials of Aβ-targeted treatment and the new concept of prion 
like propagation of intracellular abnormal proteins, tau has come back into the spotlight as a candidate therapeutic 
target in management of Alzheimer’s disease. Tau pathologies are found in a range of neurodegenerative disorders, 
but extensive analyses of pathological tau in diseased brains has indicated that the abnormal tau protein in each 
disease is structurally distinct(Avila et al., 2004), supporting the concept that progression of the diverse but 
characteristic tau pathologies occur through prion like seed dependent aggregation. Therefore, intervention in the 
conversion of normal tau to abnormal forms and in cell-to-cell transmission of tau may be the key for development 
of disease modifying treatment of AD and other memory deficits (Hasegawa, 2016).  
 
1.5. Drug Targets  
The tau and amyloid hypothesis has led to focus on tau and amyloid as treatment targets. The current therapeutic 
goals are to decrease amyloid levels and prevent amyloid toxicity/ aggregation and tau 
aggregation/phosphorylation. AD has a heterogenous cause with a large percentage termed sporadic AD arising 
from unknown etiology and a smaller fraction of early onset familial AD caused by mutation in various genes, 
such as the persenilins (PS1, PS2) and β amyloid precursor protein (APP) (Tang, 2003; Bird, 2008). Other genes 
such as apolipoprotein E (APOE) are considered to be a risk factor for AD (Kim et al., 2009). Various proteins 
such as APOE, APP, BACE (Aβ cleaving enzyme), PS1/2, secretases and tau play an important role in the 
pathogenesis of AD. Therefore, research is focused to develop new inhibitors for PS1, BASE and secretase for 
treatment of AD. There is also a significant advancement in understanding the cholinesterase function in the brain 
and the use of cholinesterase inhibitors in management of AD (Wilkinson et al., 2004; Yiannopoulou and 
Papageorgiou, 2013). The mechanism of new generation of acetyl and butyryl cholinesterase inhibitors is being 
studied and investigated in clinical trials for AD (Grossberg, 2003).  
Other strategies, such as hormone therapy, anti-oxidants, cholesterol lowering agents, anti-inflammatory agents 
and vaccinations are also being investigated for treating AD (Lahiri et al., 2002).  
 
1.6. Management of Alzeheimers Diseae 
1.6.1. Drug Treatment  
The demonstration of damage to the cholinergic pathways in the brain leads to great interest in drug development. 
Acetylcholinesterase inhibitors are usually prescribed to treat AD. These drugs help in enhancing cognitive 
functions such as memory and thoughts. These medicines are effective in patients with mild to moderate AD 
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(Houghton and Howes, 2005). Tacrine (a cholinesterase inhibitor) at a high dose (160 mg/d) was reportedly used 
in the treatment of AD (Schneider, 2000). Tacrine was investigated in both clinical trials and neuropsychological 
test scores, in a 30 week randomized placebo controlled trial (Knapp et al., 1994). However, the use of tacrine is 
limited due to adverse effects such as hepatotoxicity (Watkins et al., 1994). Anti-oxidants are effective for AD 
because they aid in reducing the free radicals that damage the brain cells (Howes and Houghton, 2012). Probiotics 
have been reported for their efficacy to enhance memory (Lyte, 2011). Probiotics are used as antidepressant in AD. 
It reduces anxiety like behavior and attenuates psychological stress. Neurochemicals are produced by microbes.  
Immunological and neurological effects are induced by probiotics. Probiotics also have immunomodulating 
activity (Misra and Medhi, 2013).  
1.6.2. Treatment using Medicinal Plants 
1.6.2.1 Management of Alzheimer’s disease 
Alzheimers disease is a neurodegenerative condition and the most well-known reason for dementia in the old. 
Despite the fact that the focal point of doctors is the administration of cholinesterase inhibitors in managing AD, 
it is vital that doctors build up a worldwide administration procedure for their patients. Early and accurate diagnosis 
of AD helps the patient  and physician  to manage the disease at onset.  
1.6.1 Drug Therapy  
This class of medication is presently regarded as the standard treatment of AD. There are four cholinesterase 
inhibitors which have been approved by the U.S. Food and Drug Administration (FDA) for the treatment of mild 
to moderate AD. These inhibitors increase the concentration of acetylcholine and the duration of its action in 
synapses by inhibiting the degradation of acetylcholine. There is also accumulating evidence that cholinesterase 
inhibitors may improve behavioral and psychological symptoms of AD, such as psychosis and apathy (Cummings, 
2000). 
1.6.2 Tacrine 
Tacrine was the first cholinesterase inhibitors to be endorsed specifically for the symptomatic treatment of patients 
with mild to moderate AD. The beginning portion for tacrine is 10 mg at 4 times daily, and this dose is increased 
by 40 mg/day for up to 4 weeks (according to tolerance), to a maximum daily dose of 160 mg (40 mg 4 times 
daily). Tacrine has been associated with hepatotoxicity (Watkins et al., 1994) and thus requires baseline and 
multiple follow-up liver enzyme determinations. 
Tacrine is extensively metabolized by the liver via the cytochrome P450 1A2 isoenzyme system; therefore, it has 
the potential to interact with other medications metabolized by this isoenzyme, such as theophylline, fluvoxamine, 
and cimetidine. Tacrine should be avoided in patients with liver disease. 
1.6.3 Donepezil 
Donepezil was the second cholinesterase inhibitor approved by the FDA for symptomatic treatment of mild to 
moderate AD in the United States. Donepezil is largely metabolized by the liver, although some of the dose is 
recovered in the urine as unchanged drug (11–17%) (Dooley et al., 2000). Clinically relevant drug interactions 
with other drugs have not been extensively studied. Interaction with paroxetine (patient developing increased 
confusion and agitation) has been reported (Carrier, 1999). Caution should be exercised in using donepezil in 
patients with severe hepatic or renal disease. 
1.6.4 Rivastigmine  
This was the third cholinesterase inhibitor approved by the FDA for symptomatic treatment of mild to moderate 
AD in the United States. Rivastigmine should be titrated every 4 weeks, as opposed to every 2 weeks, as 
recommended when the drug was first made available. One unique feature of rivastigmine that distinguishes it 
from other cholinesterase inhibitors is the very low risk of drug interactions in AD patients receiving multiple 
medications .This is because the metabolism of rivastigmine occurs primarily via enzymatic cleavage (hydrolysis) 
by cholinesterases at the site of action and does not require the cytochrome P450 enzyme system. 
1.6.5 Galantamine 
This was the fourth cholinesterase inhibitor approved by the FDA for symptomatic treatment of mild to moderate 
AD in the United States. Metabolism is hepatic via glucuronidation and the cytochrome P450 isoenzymes; 
interactions with other drugs that are metabolized through this pathway are therefore possible. Caution should be 
used in patients with liver disease. The starting dose is 4 mg twice a day, and this dose is increased every 4 weeks. 
The therapeutic dose is 16–24 mg/day. A 6-month study showed no additional benefit and a higher rate of side 
effects with a dose of 32 mg/day (Raskind et al., 2000). 
 
1.7 Medicinal Plants Used in Treating AD in Africa  
Plants provide wealth of bioactive compounds, which exert a substantial strategy for the treatment of neurological 
disorders such as Alzheimer’s disease (Carpinella et al., 2009).  In the light of this fact, polyphenolic compounds 
from vegetables and plants have been exploited because of their potential antioxidative properties ( Ak and Gulcin, 
2008). Since there has been growing focus on traditional herbal medicines presently due to the failure of existing 
treatments, we therefore provide an insight into the therapeutic avenue of medicinal plants used in Africa for 
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treatment of Alzheimer’s disease. 
1.7.1 Drumstick Tree (Moringa oleifera) 
Moringa Oleifera (MO), a plant from the family Moringacea is a major crop in Africa and Asia (Padayachee and  
Baijnath, 2012). MO is grown for its nutritious pods, edible leaves and flowers and can be utilized as food, 
medicine, cosmetic oil or forage for livestock. Its height rangesfrom 5 to 10 m (Padayachee and  Baijnath, 2012). 
MO has been recognized as containing a great number of bioactive compounds (Saini et al., 2016; Martin et al., 
2013). The most used parts of the plant are the leaves, which are rich in vitamins, carotenoids, polyphenols, 
phenolic acids, flavonoids, alkaloids, glucosinolates, isothiocyanates, tannins and saponins (Leone et al., 2015). 
The roots, bark, gum, fruit (pods), flowers, seed, and seed oil of MO are reported to have various biological 
activities, including protection against antidiabetic (Oyedepo et al., 2013), hypotensive (Faizi et al., 1998) and 
anti-inflammatory effects (Rao et al., 1998). MO leaves also protect against oxidative stress (Anwar et al., 2007), 
inflammation (Mahajan et al., 2009), hepatic fibrosis (Hamza, 2010), liver damage (Pari and Kumar, 2002), 
hypercholesterolemia (Halaby et al., 2013; Okwari et al., 2013), bacterial activity (Walter et al., 2011), cancer 
(Anwar et al., 2007), and liver injury (Efiong et al.,2013). The enormous number of bioactive compounds might 
explain the therapeutic properties of MO leaves.  
Moringa Oleifera contains significant antioxidant properties and might be used to protect against neurological 
disorders. For example, MO leaf extract contains vitamin A (Ferreira et al., 2008) which can prevent oxidative 
stress through its antioxidant properties and enhance memory through nootropics activities. The extract of MO 
leaves also contains tannins, saponins, flavonoids, terpenoids and glycosides, which have medicinal properties. 
These compounds have been shown to be effective antioxidants, anti-carcinogenic agents and anti-inflammatory 
properties (Ayoola et al., 2008; Davinelli et al.,2015). Since oxidative stress, neuroinflammation, and calcium 
homeostasis disturbances are components of Alzheimers brains that lead to increased in Aβ production, MO which 
has agents with multiple antioxidative components could be a possible therapeutic option for this disease.  
1.7.2  Tumeric (Curcuma longa) 
Turmeric is a sterile plant and does not produce any seeds. The underground rhizomes or roots of the plant are 
used for medicinal and food preparation. The rhizome is an underground stem that is thick and fleshy ringed with 
the bases of old leaves. Rhizomes are boiled and then dried and ground to make the distinctive bright yellow spice, 
turmeric. 
A study conducted at UCLA found that curcumin may help the macrophages to clear the amyloid plaques 
found in Alzheimer's disease. The most prominent characteristic feature in AD is the presence of beta-amyloid 
plaques. These plaques are basically an accumulation of small fibers called beta amyloid fibrils. Because the 
deposition of betaamyloid protein is a consistent pathological hallmark of brains affected by AD, the inhibition of 
A-beta generation, prevention of A-beta fibril formation, destabilization of pre-formed A-beta would be an 
attractive therapeutic strategy for the treatment of AD. Curcumin has been shown to increase the phagocytosis of 
amyloidbeta, effectively clearing them from the brains of patients with AD (Fiala et al., 2007). 
 Macrophages play an important role in the immune system. They help the body to fight against foreign 
proteins and then effectively clear them. Curcumin was treated with macrophages in blood taken from nine 
volunteers: six AD patients and three healthy controls. Beta amyloid was then introduced. The AD patients, whose 
macrophages were treated with curcumin, when compared with patients whose macrophages were not treated with 
curcumin, showed an improved uptake and ingestion of the plaques. Thus, curcumin may support the immune 
system to clear the amyloid protein (Zhang et al., 2006). 
One of the important pathogenesis in Alzheimer's disease is the chronic inflammation of nerve cells. 
Several studies have demonstrated the associated inflammatory changes such as microgliosis, astrocytosis 
and the presence of pro-inflammatory substances that accompany the deposition of amyloid-β (Aβ) peptide. 
Patients with the prolonged use of certain nonsteroidal anti-inflammatory (NSAID) drugs such as ibuprofen have 
been shown to have a reduced risk of developing the symptoms of AD; however, the chronic use of NSAID can 
cause a toxic effect on the kidneys, liver and GI track. 
Curcumin has a potent anti-inflammatory effect. Through its various anti-inflammatory effects, it may have 
a role in the cure of AD caused by oxidation and inflammation (Frautschy and Hu,2001). 
1.7.3 Aged Garlic Extract (Allium sativum) 
Garlic and its preparations have been widely recognized as agents for prevention and treatment of cardiovascular 
and other metabolic diseases, atherosclerosis, hyperlipidemia, thrombosis, hypertension, dementia, cancer and 
diabetes (Lawson, 1998). The medicinal use of garlic has a long history. Over the centuries, garlic has acquired a 
special position in the folklore of many cultures as a formidable prophylactic and therapeutic medicinal agent 
(Moyer, 1996). Garlic has attracted particular attention of modern medicine because of its widespread use around 
the world and the cherished belief that it helps to maintain good health by warding off illness and providing more 
vigor. 
The health benefits of garlic as a neuroprotective agent are beginning to emerge (Carmia, 2006).  Raw garlic 
homogenate has been the major preparation of garlic subjected to intensive scientific study, because it is the most 
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common method of garlic consumption. Raw garlic homogenate is essentially the same as the aqueous garlic 
extract which has been used in various scientific studies. Allicin (allyl 2-propene thiosulfinate or 
Diallylthiosulfinate was long thought to be the principal bioactive compound present in aqueous extract or raw 
garlic homogenate( Augusti and Mathew, 1975). When garlic is chopped or crushed, allinase enzyme, present in 
garlic is activated and acts on alliin (present in whole garlic) to produce allicin (Fenwick and Hanley, 1985). Other 
important sulfur-containing compounds present in garlic homogenate are allyl methyl thiosulfonate, 1-propenyl 
allylthiosulfonate and -L-glutamyl-S-alkyl-L-cysteine (block, 1985). The enzyme allinase responsible for 
converting alliin (S-allylcysteine sulfoxide) to allicin is inactivated by heat (Lawson, 1998). Thus the water extract 
of heat treated garlic contains primarily alliin.  
AGE has the potential to protect the brain against neurodegenerative conditions (Brown and Gwebu, 2003) 
by preventing brain injury following ischemia (Numagami et al., 1996), protecting neuronal cells against apoptosis 
(Brown and Gwebu, 2003; Mbyirukira and Gwebu, 2003; Kasuga et al., 2001) , and preventing β-amyloid-induced 
oxidative death (Griffin et al., 1998). Moreover, treatment with AGE or S-allyl cysteine has been shown to prevent 
the degeneration of the brain’s frontal lobe, improve learning and memory retention, and extend lifespan 
(Nishiyama et al.,1997).  
1.7.4  Cattle stick (Carpolobia lutea) 
Carpolobia lutea  is a perennial shrub native to West and Central Tropical Africa. It is widely distributed in 
rainforests and the Guinea savannah of Sierra Leone, Cameroon and Nigeria. Extracts and fractions of C. lutea 
have hitherto only been reported anecdotally to possess benefits to cognition, with the study of C. lutea that has 
included an examination of its antidiarrheal (Nwidu, Essien et al., 2011), anti-nociceptive (Nwidu,Nwafor et al. 
2011) and gastro-protective effects (Nwidu et al.2014). 
The presence of secondary metabolites such as polyphenols and flavonoids compounds that include flavones 
and isoflavones  exhibiting scavenging (antioxidant) activities in Carpolobia lutea have been effective in delaying 
the progression of AD. These antioxidants may counter free radical damage produced during metabolism and for 
which radical levels may be exacerbated in AD (Parihar and Hemnani 2004; Zhao and Zhao, 2013). A recent in 
vivo study by Ajiwhen and Bisong (2013) administered a low-dose (1500 mg/kg p.o.) of C. lutea root extract to 
mice and reported cognitive memory enhancing activity, and this may reflect the potent anti-AChE activity 
described herein. At this dose of C. lutea roots, no toxicity to mice was reported (Ajiwhen and Bisong 2013). 
1.7.5 Lemon Balm (Melissa officinalis) 
Melissa officinalis (MO, English: lemonbalm, Lamiaceae), one of the oldest and still most popular aromatic 
medicinal plants, is used in phytotherapy for the prevention and treatment of nervous disturbances of sleep and 
gastrointestinal disorders as sedative and antispasmodic medicine. New neuropharmacological investigations 
showed that ethanol extracts of MO exerted also neuroprotective (Bayat et al.,2012; Kamdem et al., 2013), 
antioxidant, cyclooxygenase-2 inhibitory(Lin et al., 2012), and antinociceptive activities (Kamdem et al., 2013; 
Guginski, 2009). Moreover, it is known that MO is used for memory-enhancing effects in European folk medicine 
(Perry et al., 1996; Perry et al., 1999; Orhan and Aslan,2009). 
Indeed, Akhondzadeh et al. (Akhondzadeh et al., 2003) carried out the clinical trial in which MO extract 
produced a significantly better outcome on cognitive function than placebo in patients with mild to moderate 
Alzheimer’s disease. MO is traditionally used in treating neurological disorders through its anti-AChE (Soodi et 
al.,2014) and antiagitation properties (Abuhamdah et al., 2008). Moreover, Wake et al.( Wake et al., 2000) and 
Kennedy et al. (Kennedy et al., 2003) showed that MO extract has nicotinic 
receptor activity and that it can displace [3H]-(N)-nicotine from nicotinic receptors in homogenates of human 
cerebral cortex tissue and they suggested that these mechanisms can explain activity of MO extract in amnesia 
model. This plant extract is a complex mixture, and its action may be a result of the summation of activities of 
several components (synergism/additive action of caffeic acid with salvianolic acids, rosmarinic acid, and others). 
1.7.6   Garden Sage (Salvia officinalis) 
Salvia officinalis comes from the Latin word meaning ‘to heal’ and is widely used in both culinary and medicinal 
preparations. Many species of Salvia are native to Mediterranean Europe and have been traditionally used for the 
treatment of a range of problems including digestive and circulation disturbances, bronchitis, coughs, asthma, 
memory problems, angina, mouth and throat inflammation, depression and excessive sweating. Salvia plants are 
traditionally noted for their antioxidant effects and ability to enhance ‘head and brain’ function, improve memory, 
quicken the senses, and delay age-associated cognitive decline (Perry et al., 1999). Salvia plants are a rich source 
of polyphenol compounds with over 160 identified polyphenols, comprising an array of phenolic acids and 
flavonoids. These phenolic compounds include caffeic acid and its derivatives, rosmarinic acid, salvianolic acids, 
sagecoumarin, lithospermic acids, sagernic acid, and yunnaneic acids. The most prevalent flavonoids include 
luteolin, apigenin, hispidulin, kaempferol and quercetin (Lu and Foo, 2002). Plants of the genus Salvia are also 
rich in essential oils, with a large array of terpenoids including a and b-thujone, camphor, 1,8-cineole, a-humulene, 
b-caryophyllene and viridiflorol. Moreover, they are rich sources of diterpenes and triterpenes such as carnosic 
acid, ursolic acid, carnosol and tanshinones. 
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In vitro and animal studies have revealed that several Salvia species and their constituents are effective AChE 
inhibitors. An aqueous extract of S. officinalis lowered AChE activity in mice (Smash et al., 2015), and in vitro 
analyses revealed that ethanolic extracts of S. officinalis reduced AChE, with greater effects on 
butyrylcholinesterase (Kennedy et al., 2006; Scholey et al., 2008). AChE inhibition has also been observed from 
the phenolic diterpenes, 7amethoxyrosmanol and isorosmanol, isolated from S. officinalis (Sallam et al., 2016). 
The active constituents, rosmarinic acid, carnosic acid and quercetin, found in several Salvia species can also 
inhibit AChE activity (Sallam et al., 2016; Merad et al.,2014; Marcelo et al., 2013)  
 
1.8 Conclusion 
The prevalence of neurodegenerative disease such as Alzheimer’s disease is increasing due to an ever ageing 
population; however treatment of this disease is still limited. An herbal approach of systematic screening of natural 
plants is a cost effective strategy of developing novel drug treatments. Thus, these plants remain a potentially 
beneficial pharmacotherapy in Africa that could be further developed for the treatment of AD and/or other 
neurodegenerative diseases such as Parkinson’s disease to address these cholinergic deficits. 
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